AEYE Health

🌟 October Highlights: Celebrating Connections and Innovations! 🌟 This month, we had the pleasure of connecting with so many of you at major conferences, where we showcased Aurora AEYE—the first and only FDA-cleared portable AI solution for diabetic eye exams. With quick, 1-minute exams that require no dilation, Aurora AEYE brings accessible and efficient screening to clinical settings and patients' homes, reimbursable under CPT 92229, bridging the diabetic eye exam care gap. A heartfelt thank you to everyone who joined us at: American Academy of Ophthalmology (AAO) Annual Meeting in Chicago- exploring AEYE-DS's impact on retinal screening and patient outcomes. California Primary Care Association (CPCA) Conference in Sacramento and the American Academy of Home Care Medicine (AAHCM) Annual Meeting in Phoenix, where, alongside Optomed US, presenting Aurora AEYE for in-clinic and in-home use. HLTH Inc. in Las Vegas, introducing attendees to our 1-minute, on-the-spot screening solution that delivers instant results with no dilation required! We would love to continue the conversation with all of you and explore how we can work together to advance diabetic eye care. Thank you for your support and enthusiasm! Here’s to making a difference together! 👁️✨ #AAO2024 #CPCA24AC #AAHCM2024 #HLTHUSA #HLTH2024 #AIinHealthcare #RetinalScreening #Ophthalmology #AEYEHealth #DiabeticRetinopathy

🌟 Only two days left at the HLTH Inc. conference! We had an incredible first day connecting with healthcare professionals, and we're excited for what's to come! If you're attending, don't miss the chance to visit us at booth #2254 (kiosk 7) and experience Aurora AEYE, the first and only FDA-cleared portable AI solution for diabetic eye exams! Our groundbreaking technology offers 1-minute, on-the-spot screenings with instant results—all without dilation. It’s designed for seamless integration into both clinical and home care settings, making it easier than ever to close the diabetic eye exam care gap and improve patient outcomes. Plus, it's reimbursable under CPT 92229! 📅 Book a demo here: https://lnkd.in/gDcBMU4b Don’t miss out on seeing how Aurora AEYE is revolutionizing diabetic eye care! 👁️💡 #HLTHUSA #HLTH2024 #AIHealthcare #DiabeticEyeCare #PortableAI #PatientOutcomes #DiabeticRetinopathy

🌟 Visit us tomorrow at HLTH Inc. to see the first FDA-cleared portable AI solution for diabetic eye exams at booth #2254 (kiosk 7)! Our revolutionary technology delivers 1-minute, on-the-spot screenings with instant results—no dilation required—at any point of care! Designed for seamless integration into both clinical and home care settings, Aurora AEYE enhances access to care, helps close the diabetic eye exam care gap, and boosts patient outcomes. Plus, it’s reimbursable under CPT 92229! 📅 Book a demo here: https://lnkd.in/gAzKMr58 Stop by to discover how we’re advancing diabetic eye care! 👁️💡 #HLTHUSA #HLTH2024 #AIHealthcare #DiabeticEyeCare #PortableAI #PatientOutcomes

🌟 AEYE Health & Optomed US: Joint Exhibitions at Two Upcoming Conferences! We’re thrilled to collaborate with Optomed US to showcase Aurora AEYE, the first FDA-cleared portable AI solution for diabetic eye exams. This cutting-edge technology allows for 1-minute, on-the-spot screenings during routine visits, delivering instant results without the need for dilation. With seamless integration into both clinical and home care settings, Aurora AEYE enhances access to care, helps close the diabetic eye exam care gap, and improves patient outcomes- plus, it’s reimbursable under CPT 92229. Join us at either event to explore how Aurora AEYE can transform your care delivery. We look forward to seeing you there! 📅 California Primary Care Association (CPCA) Conference 📍 Sacramento, CA | October 17-18 | Booth #220 📅 Book a demo here: https://lnkd.in/gkXTnq6X 📅 American Academy of Home Care Medicine (AAHCM) Annual Meeting 📍 Phoenix, AZ | October 18-19 | Booth #310 📅 Schedule a demo here: https://lnkd.in/g-x_nSGq #CPCA2024 #AAHCM2024 #AIinHealthcare #PortableAI #DiabeticEyeExams #AEYEHealth #OptomedUS

🌟 Exciting News! 🌟 AEYE Health will be at the American Academy of Ophthalmology (AAO) Annual Meeting in Chicago from October 18-21! Join us to discover AEYE-DS, our FDA-cleared AI technology that’s transforming retinal screening and improving patient outcomes. We’re excited to share how this cutting-edge solution is shaping the future of ophthalmology. Let’s connect! 📅 Email us at bd@aeyehealth.com to schedule a meeting. See you in Chicago! 👁️ #AAO2024 #AIinHealthcare #RetinalScreening #Ophthalmology #AEYEHealth

Thank you to everyone who visited us at the American Academy of Family Physicians FMX 2024! 🙌 It was a pleasure meeting so many of you and having meaningful discussions about how our FDA-cleared diabetic retinopathy screening technology can make a difference in your practice. 👁️💡 We’re excited about the future of family medicine and the role AI can play in closing diabetes care gaps, both in clinics and during home visits. Your insights and enthusiasm inspire us, and we’re looking forward to continuing the conversation. 💬✨ Stay connected, and let’s keep working together to enhance patient care! 👏 #AAFPFMX

🚀 Just one week to go until FMX 2024! We’re excited to announce that AEYE Health will be showcasing our cutting-edge, FDA-cleared AI diagnostic screening for diabetic retinopathy at the American Academy of Family Physicians FMX 2024! 🩺✨ Join us at Booth #2557 in Phoenix, AZ, from September 25-27 to experience our 1-minute AI diabetic retinopathy screening solution. Our solution provides on-the-spot results with just one image per eye, streamlining early detection and management without needing specialist involvement. ✨ Don’t miss your chance to witness this game-changing technology firsthand. Book an exclusive demo and see how our AI is revolutionizing diabetes care! Reserve your spot today: https://lnkd.in/gWnX2WPx #AAFPFMX

We're thrilled to announce that AEYE Health will be exhibiting at the American Academy of Family Physicians FMX 2024! Join us to experience our FDA-cleared AI diagnostic screening for diabetic retinopathy, delivering on-the-spot results at any point of care.🩺✨ Visit us at Booth #2557 from September 25-27 in Phoenix, AZ, and discover how our innovative AI screening is transforming diabetes care. With just one image per eye and instant AI diagnoses, our solution eliminates the need for specialist involvement, making early detection and management of diabetic retinopathy more accessible and efficient. ✨Don’t miss out—book an exclusive demo and see the future of diabetes care in action! Book your demo today: https://lnkd.in/gWnX2WPx

🎉 We’re honored to share that our CEO, Zack Dvey-Aharon, has been included in TIME’s 100 Most Influential People in Artificial Intelligence! Zack, Co-Founder of AEYE Health, was recognized for his dedication to advancing AI-driven healthcare. Under his leadership, AEYE Health’s Diagnostic Screening became the first FDA-cleared portable AI screening solution for diabetic retinopathy. This recognition reflects our ongoing commitment to improving patient care through innovative technology. And we’re just getting started. While diabetic retinopathy screening is a major milestone, we’re expanding our AI systems to screen for a range of other conditions, including cardiovascular disease, age-related macular degeneration, glaucoma, and hypertension. As Zack explains, retinal scans are incredibly valuable for medical diagnoses because the eyes can reveal so much about overall health. We’re grateful for the support and recognition and are excited to continue our journey of transforming healthcare. 🚀 https://lnkd.in/ejQTy8sM #AI #HealthcareInnovation #DiabeticRetinopathy #PatientCare #AIinHealth #TIME100AI #AIEyeCare #HealthTech

🎉 We’re honored to share that our CEO, Zack Dvey-Aharon, has been included in TIME’s 100 Most Influential People in Artificial Intelligence! Zack, Co-Founder of AEYE Health, was recognized for his dedication to advancing AI-driven healthcare. Under his leadership, AEYE Health’s Diagnostic Screening became the first FDA-cleared portable AI screening solution for diabetic retinopathy. This recognition reflects our ongoing commitment to improving patient care through innovative technology. And we’re just getting started. While diabetic retinopathy screening is a major milestone, we’re expanding our AI systems to screen for a range of other conditions, including cardiovascular disease, age-related macular degeneration, glaucoma, and hypertension. As Zack explains, retinal scans are incredibly valuable for medical diagnoses because the eyes can reveal so much about overall health. We’re grateful for the support and recognition and are excited to continue our journey of transforming healthcare. 🚀 https://lnkd.in/ejQTy8sM #AI #HealthcareInnovation #DiabeticRetinopathy #PatientCare #AIinHealth #TIME100AI #AIEyeCare #HealthTech